Previous studies have shown that D-gal/AlCl3 can cause decreased memory and learning abilities, Aβ deposition, and enhanced p-tau expression, and provide an effective non-transgenic AD-like injury model (Zhang et al., 2016a; An et al., 2017; Chiroma et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.